Bookmark and Share

Publications - HIV/HTLV

Tacket CO, Baqar S, Munoz C, Murphy JR. Lymphoproliferative responses to mitogens and HIV-1 envelope glycoprotein among volunteers vaccinated with recombinant GP160. AIDS Research and Human Retroviruses 1990;6:533-540.

Kotloff K. Diarrea en niños con sindrome de inmunodeficiencia adquirida. Boletín de la Escuela de Medicina, Pontificia Universidad Católica de Chile 1988;18:65-68.

Archibald DW, Hebert CA, Sun D, Tacket CO. Salivary antibodies to human immunodeficiency virus type 1 in phase 1 AIDS vaccine trial. J. AIDS 1990;3:954-958.

Dolin R, Graham BS, Greenberg SB, Tacket CO, Belshe RB, Midthun K, Clements ML, Gorse GJ, Horgan BW, Atmar RL, Karzon DT, Bonnez W, Fernie BF, Montefiori DC, Stablein DM, Smith GE, Koff WC. Safety and immunogenicity of an HIV-1 recombinant GP160 candidate vaccine in humans. Ann. Int. Med. 1990;114:119-127.

Kotloff KL, Tacket CO, Clemens JD, Wasserman SS, Cowan JE, Bridwell MW, Quinn TC. Assessment of the prevalence and risk factors for HIV-1 infection among college students using three survey methods. Amer. J. Epidemiol. 1990;133:2-8.

Schulof RS, Parenti DM, Simon GL, Paxton H, Meyer, III WA, Schlesselman SB, Courtless J, LeLacheur S and Sztein MB. Clinical, virologic and immunologic effects of combination therapy with ribavirin and isoprinosine in HIV-infected homosexual men. J. AIDS 1990;3:485-492.

Tacket CO, Baqar S, Munoz C, Murphy J. Lymphoproliferative responses to mitogens and HIV-1 envelope glycoprotein among volunteers vaccinated with recombinant GP160. AIDS Research and Human Retroviruses 1990;6:533-540.

Clerici, M, Berzofsky JA, Shearer GM, Tacket, CO. Exposure to HIV-1 indicated by HIV-specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies. J. Infect. Dis. 1991;164:178-182.

Clerici, M, Tacket, CO, Via, CS, Lucey DR, Muluk, SC, Zajac, RA, Boswell, RN, Berzofsky, JA, Shearer, GM. Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infection. Eur. J. Immunol. 1991;21:1345-1349.

Dolin R, Graham BS, Greenberg SB, Tacket CO, Belshe RB, Midthun K, Clements, ML, Gorse GJ, Horgan BW, Atmar RL, Karzon DT, Bonnez W, Fernie BF, Montefiori DC, Stablein DM, Smith GE, Koff WC. Safety and immunogenicity of an HIV-1 recombinant gp160 candidate vaccine in humans. Ann. Int. Med. 1991;114:119-127.

Gotuzzo E, Frisancho O, Sanchez J, Liendo G, Carrillo C, Black RE, Morris JG. Association between the acquired immunodeficiency syndrome and infection with Salmonella typhi or paratyphi in an endemic area. Arch. Int. Med. 1991;151:381-2.

Kotloff KL, Tacket CO, Clemens JD, Wasserman SS, Cowan JE, Bridwell MW, Quinn TC. Assessment of the prevalence and risk factors for HIV-1 infection among college students using 3 survey methods. Amer. J. Epidemiol. 1991;133:2-8.

Kotloff KL, Tacket CO, Wasserman SS, Bridwell MW, Cowan JE, Clemens JD, Brothers TA, O'Donnell SA, Quinn TC. A voluntary serosurvey and behavioral risk assessment for human immunodeficiency virus infection among college students. Sexually Transmitted Diseases 1991;18:223-227.

Naylor PH, Sztein MB, Wada S, Maurer S, Holterman D, Kirkley JE, Naylor CW, Zook BC, Hitzelberg RA, Gibbs CJ Jr., Zagury D, Achour A, O'Toole C, Gazzard B, Youle M, Rios A, Sarin PS, Goldstein AL. Preclinical and clinical studies on immunogenicity and safety of HIV-1 p17 based synthetic peptide AIDS vaccine - HGP-30-KLH. Int. J. Immunopharmacol. 1991;13:117-127.

Clerici M, Berzofsky JA, Shearer GM, Giorgi JV, Tacket C. On HIV-serologic testing of blood and tissue donors. New England Journal of Medicine 1992;327:564-565.

Keiser P, Fernie B, Tacket C, Wecksler W, Keay S. Anti-CD4 Antibodies Generated in Response to HIV-1 rgp160 Immunization of HIV-1 Infected Chimpanzees. AIDS, 1993, 7, 136-138.

Kotler DP, Giang, TT, Thiim, M, Nataro, JP, Sordillo, EM, Orenstein, JM. Chronic bacterial enteropathy in patients with AIDS. Journal of Infectious Diseases 171:552-558, 1995.

Keay S, Wechsler W, Wasserman SS, Margolick J, Farzadegan H. Association between Anti-CD4 antibodies and a decline in CD4(+) lymphocytes in human immunodeficiency virus type 1 seroconverters. Journal of Infectious Diseases, 1995, 171:312-319.

Levin A, Brubaker G, Shao JS, Kumby D, O'Brien TR, Goedert JJ, Strauss KW, Blattner WA, Hannet I. Determination of T-lymphocyte subsets on site in rural Tanzania: results in HIV-1 infected and non-infected individuals. Int. J. STD AIDS 1996;7:288-291.

O'Brien TR, Blattner WA, Waters D, Eyster E, Hilgartner MW, Cohen AR, Luban N, Hatzakis A, Aledort LM, Rosenberg PS, Miley WJ, Kroner BL, Goedert JJ. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA 1996;276:105-110.

Rabkin CS, Corbin DO, Felton S, Barker H, Davison D, Dearden C, Blattner WA, Evans AS. Human T-cell lymphotropic virus type I infection in Barbados: results of a 20-year follow-up study. J. AIDS Hum. Retrovirol. 1996;12:519-522.

Robbins KE, Bandea CI, Levin A, Goedert JJ, Blattner WA, Brubaker G, Brown TM, Schochetman G, Kalish ML, Shao J, O'Brien TR. Genetic variability of human immunodeficiency virus type 1 in rural northwest Tanzania. AIDS Res. Hum. Retroviruses 1996;12:1389-1391.

Carrington M, Stephens JC, Ma WY, Martin M, Harding A, Noble J, Erlich H, Mann D, Arango C, Jaramillo R, Concha M, Maloney E, Blattner W. Identification of a novel TAP2 allele in a Colombian black population: gene conversion, ancestral intermediate or convergent change? Mol. Biol. Evol. 1997;14:892-894.

Cote TR, Biggar RJ, Rosenberg PS, Devesa SS, Percy C, Yellin FJ, Lemp G, Hardy C, Geodert JJ, Blattner WA. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group. Int. J. Cancer 1997;73:645-650.

Figueroa JP, Ward E, Morris J, Brathwaite AR, Peruga A, Blattner W, Vermund SH, Hayes R. Incidence of HIV and HTLV-1 infection among sexually transmitted disease clinic attenders in Jamaica. J. AIDS Hum. Retrovirol. 1997;15:232-237.

Sipsas NV, Kalams SA, Trocha A, He S, Blattner WA, Walker BD, Johnson RP. Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1. J. Clin. Invest. 1997;99:752-762.

Stefanova I, Saville MW, Peters C, Cleghorn FR, Schwartz D, Venzon DJ, Weinhold KJ, Jack N, Bartholomew C, Blattner WA, Yarchoan R, Bolen JB, Horak ID. HIV infection-induced posttranslational modification of T cell signaling molecules associated with disease progression. J. Clin. Invest. 1996;98:1290-1297.

Bartlett JA, Wasserman SS, Hicks CB, Dodge RT, Weinhold KJ, Tacket CO, Ketter N, Wittek AE, Palker TJ, Haynes BF. Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research Initiative. AIDS 1998;12:1291-300.

Cleghorn FR, Jack N, Murphy JR, Edwards J, Mahabir B, Paul R, O'Brien T, Greenberg M, Weinhold K, Bartholomew C, Brookmeyer R, Blattner WA. Direct and indirect estimates of HIV-1 incidence in a high-prevalence population. Am. J. Epidemiol. 1998;147:834-9.

Dada AJ, Ajayi AO, Diamondstone L, Quinn TC, Blattner WA, Biggar RJ. A serosurvey of Haemophilus ducreyi, syphilis, and herpes simplex virus type 2 and their association with human immunodeficiency virus among female sex workers in Lagos, Nigeria. Sex. Transm. Dis. 1998;25:237-42.

La Grenade L, Manns A, Fletcher V, Derm D, Carberry C, Hanchard B, Maloney EM, Cranston B, Williams NP, Wilks R, Kang EC, Blattner WA. Clinical, pathologic, and immunologic features of human T-lymphotrophic virus type I-associated infective dermatitis in children. Arch. Dermatol. 1998;134:439-44.

Lichenstein R, King JC Jr, Farley JJ, Su P, Nair P, Vink PE. Bacteremia in febrile human immunodeficiency virus-infected children presenting to ambulatory care settings. Pediatr. Infect. Dis. J. 1998;17:381-5.

Lunardi-Iskandar Y, Bryant JL, Blattner WA, Hung CL, Flamand L, Gill P, Hermans P, Birken S, Gallo RC. Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease. Nature Med. 1998;4:428-34.

Maloney EM, Cleghorn FR, Morgan OS, Rodgers-Johnson P, Cranston B, Jack N, Blattner WA, Bartholomew C, Manns A. Incidence of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad. J. AIDS Hum. Retrovirol. 1998;17:167-70.

Blattner WA. Human retroviruses: their role in cancer. Proc. Assoc. Amer. Physicians. 1999;Nov-111:563-72.

Brander C, Yang OO, Jones NG, Lee Y, Goulder P, Johnson RP, Trocha A, Colbert D, Hay C, Buchbinder S, Bergmann CC, Zweerink HJ, Wolinsky S, Blattner WA, Kalams SA, Walker BD. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences. J. Virol. 1999;73:10191-8.

Garzino-Demo A, Moss RB, Margolick JB, Cleghorn F, Sill A, Blattner WA, Cocchi F, Carlo DJ, DeVico AL, Gallo RC. Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status. Proc Natl Acad Sci U S A. 1999;96:11986-91.

Maloney EM, Armien B, Gracia F, Castillo L, Kruger H, Levin A, Levine PH, Kaplan JE, Blattner WA, Giusti RM. Risk factors for human T cell lymphotropic virus type II infection among the Guaymi Indians of Panama. J. Infect. Dis. 1999;180:876-9.

Manns A, Miley WJ, Wilks RJ, Morgan OS, Hanchard B, Wharfe G, Cranston B, Maloney E, Welles SL, Blattner WA, Waters D. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection. J. Infect. Dis. 1999;180:1487-93.

Oursler KA, Moore RD, Chaisson RE. Risk factors for cryptococcal meningitis in HIV-infected patients. AIDS Res. Hum. Retroviruses. 1999;15:625-31.

Sambor AM, Pombo de Oliveira MS, Farhadi A, Carr JK, Carvalho SM, Blattner WA, Kim JH. Human T-lymphotropic virus type I tax polymorphisms in a transmission cohort: no association between sequence variation and disease manifestations. J. Hum Virol. 1999;2:308-14.

Baron P, Bremer J, Wasserman SS, Nowicki M, Driscoll B, Polsky B, Kovacs A, Reichelderfer PS. Detection and quantitation of human immunodeficiency virus type 1 in the female genital tract. J Clin Microbiol. 2000, 38:3822-4.

Cleghorn FR, Jack N, Carr JK, Edwards J, Mahabir B, Sill A, McDanal CB, Connolly SM, Goodman D, Bennetts RQ, O'Brien TR, Weinhold KJ, Bartholomew C, Blattner WA, Greenberg ML. A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago. Proc Natl Acad Sci U S A. 2000, 97:10532-7.

Cocchi F, DeVico AL, Yarchoan R, Redfield R, Cleghorn F, Blattner WA, Garzino-Demo A, Colombini-Hatch S, Margolis D, Gallo RC. Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection Proc Natl Acad Sci U S A. 2000, 97:13812-7.

Kovacs A, Wasserman SS, Burns, Wright DJ, Cohn J, Landay A, Weber K, Cohen M, Levine A, Minkoff H, Miotti P, Palefsky J, Young M, Reichelderfer P, the DATRI and WIHS study groups. Determinants of HIV-1 shedding in the genital tract of women. Lancet. 2001, 358:1593-1601.